(614)355-5560
South Central / Southeast Region
June 3, 2022
Resources for Early RSV Season

Respiratory syncytial virus (RSV) season in Ohio typically begins in the Fall and extends into the early Spring. As a result of factors related to the COVID-19 pandemic, RSV season shifted in 2021, with high community spread beginning in June and persisting through November. This year may follow a similar pattern as the Nationwide Children’s Hospital’s lab is detecting more cases of RSV. Palivizumab (Synagis®) is an intramuscular-delivered monoclonal antibody approved for infants who are high risk for severe RSV infection. In order to be effective, palivizumab should be administered each month when RSV-rates are highest in the community. A multi-disciplinary team of infectious disease doctors, neonatologists and pharmacists are reviewing the data weekly to determine when it may become appropriate to start administering palivizumab. We will keep you updated on if and when this recommendation is made ahead of the typical RSV season (i.e. November to March).

Below are some resources to help you start identifying patients eligible for palivizumab as well as how you can refer these patients to NCH Homecare for palivizumab administration. Please also find links to palivizumab prior authorization forms below for each of the Ohio Medicaid managed care plans. Do not hesitate to reach out to the PFK Pharmacy team (PFKpharmacy@nationwidechildrens.org), if you have questions regarding referrals, prior authorizations, or assessing clinical criteria for potential palivizumab candidates.

 

NCH Resources:

For Providers: Click Here

General Public: Click Here

 

Ohio Medicaid Managed Care Plan PA forms for palivizumab (Subject to change with 2022-2023 updates):

CareSource

United Healthcare Community

Molina

Buckeye Health Plan

 

 

Related Articles
Pharmacy Updates
October 6, 2022
Quarter 4 Partners For Kids Unified Preferred Drug List Now Available
Read More
Pharmacy Updates
October 6, 2022
RSV Season – Medicaid Plans Now Covering Palivizumab (Synagis®) for Qualifying Patients
Read More
Pharmacy Updates
August 18, 2022
UPDATED: Format and Content for Partners For Kids Asthma Prescribing Resource
Review the updated “Prescribing Guidelines for Asthma” that include a new pathway to assist with decision-making, clickable elements to assist navigation throughout the resource and more.
Read More
Pharmacy Updates
June 16, 2022
Flovent HFA Inhaler Now Has a Generic; Brand Still Preferred for Medicaid Patients
Learn how to ensure your patients continue to receive the brand name medication.
Read More
Pharmacy Updates
June 16, 2022
RSV Season May Start Early Again This Year
Read about the indicators suggesting an early RSV season and planned communication to providers regarding Synagis administration. Learn about RSV resources for your providers and patients.
Read More
Pharmacy Updates
December 29, 2021
CareSource Continuous Glucose Monitor Coverage Update
Read More